FRA
CLX icon

Front Row Advisors’s Clorox CLX Stock Holding History

Front Row Advisors’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-318
Closed -$33K – 580
2026
Q1 		$33K Hold
318
– – 0.01% 259
2025
Q4 		$32.1K Hold
318
– – 0.01% 253
2025
Q3 		$39.2K Hold
318
– – 0.01% 239
2025
Q2 		$38.2K Hold
318
– – 0.01% 234
2025
Q1 		$46.8K Hold
318
– – 0.02% 224
2024
Q4 		$51.6K Hold
318
– – 0.02% 215
2024
Q3 		$51.8K Hold
318
– – 0.02% 215
2024
Q2 		$43.4K Hold
318
– – 0.02% 287
2024
Q1 		$48.7K Buy
+318
New +$47.5K 0.02% 261
2021
Q1 		– Sell
-200
Closed -$40K – 956
2020
Q4 		$40K Hold
200
– – 0.02% 280
2020
Q3 		$41K Hold
200
– – 0.02% 268
2020
Q2 		$44K Hold
200
– – 0.03% 233
2020
Q1 		$37K Buy
+200
New +$33K 0.03% 252

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Front Row Advisors's CLX Position: Q2 2026 in Review

Front Row Advisors sold out of Clorox (CLX) in Q2 2026, closing a stake of 318 shares — an estimated $33K sold.

Front Row Advisors first reported a position in CLX in Q1 2020 and held it in 13 quarters. The position peaked at $51.8K in Q3 2024. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Front Row Advisors reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Front Row Advisors sold 318 Clorox shares in Q2 2026, an estimated $33K.
  • Front Row Advisors first reported a position in Clorox in Q1 2020 and held it in 13 quarters.
  • Front Row Advisors's Clorox position peaked at $51.8K in Q3 2024.
  • 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Front Row Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.